Patent details

EP2269595 Title: Titratable dosage transdermal delivery system

Basic Information

Publication number:
EP2269595
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101781193
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Titratable dosage transdermal delivery system
French Title of Invention:
Système d'administration transdermique de doses titrables
German Title of Invention:
Titrierbares transdermales Dosierungsverabreichungssystem
SPC Number:

Dates

Filing date:
13/11/2001
Grant date:
31/01/2018
EP Publication Date:
05/01/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/01/2018
EP B1 Publication Date:
31/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/11/2018
Expiration date:
13/11/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/01/2018
 
 

Name:
EURO-CELTIQUE S.A.
Address:
1, rue Jean Piret, 2350 Luxembourg, Luxembourg (LU)

Inventor

Name:
Wright, Curtis
Address:
United States (US)

Priority

Priority Number:
714604
Priority Date:
16/11/2000
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/70;

Publication

European Patent Bulletin

Issue number:
201805
Publication date:
31/01/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2019 Outgoing Correspondence 1